Patient Leaflet Updated 16-Oct-2024 | Aspire Pharma Ltd
Fesoterodine fumarate 4mg prolonged-release tablets Fesoterodine fumarate 8mg prolonged-release tablets
Fesoterodine fumarate 4mg prolonged-release tablets
Fesoterodine fumarate 8mg prolonged-release tablets
fesoterodine fumarate
1. What Fesoterodine is and what it is used for
2. What you need to know before you take Fesoterodine
3. How to take Fesoterodine
4. Possible side effects
5. How to store Fesoterodine fumarate
6. Contents of the pack and other information
This medicine contains an active substance called fesoterodine fumarate, and is a so called antimuscarinic treatment which reduces the activity of an overactive bladder and it is used in adults to treat the symptoms.
Fesoterodine treats the symptoms of an overactive bladder such as:
Fesoterodine may not always be suitable for you. Talk to your doctor before taking Fesoterodine, if any of the following apply to you:
Heart problems. Talk to your doctor if you suffer from any of the following conditions:
Do not give this medicine to children and adolescents below 18 years of age because it is yet to be established whether it would work for them and whether it would be safe.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This includes medicines obtained without a prescription, including herbal medicines. Your doctor will tell you whether you can take fesoterodine with other medicines.
Please inform your doctor if you are taking any of the following medicines. Taking them at the same time as fesoterodine may make side effects such as dry mouth, constipation, difficulty in completely emptying your bladder or drowsiness more serious or occur more often.
Please also inform your doctor if you are taking any of the following medicines:
You should not take Fesoterodine if you are pregnant, as the effects of fesoterodine on pregnancy and the unborn baby are not known.
It is not known whether fesoterodine is excreted into human milk; therefore, do not breast-feed during treatment with Fesoterodine.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
This medicine can cause blurred vision, dizziness, and sleepiness. If you experience any of these effects, do not drive or use any tools or machines.
This medicine contains lactose. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.
This medicine contains less than 1mmol sodium (23mg) per tablet, that is to say essentially ‘sodium-free’.
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
The recommended starting dose of fesoterodine is one 4mg tablet a day. Based on how you respond to the medicine, your doctor may prescribe you a higher dose; one 8mg tablet a day.
You should swallow your tablet whole with a glass of water. Do not chew the tablet. Fesoterodine can be taken with or without food.
To help you remember to take your medicine, you may find it easier to take it at the same time every day.
If you have taken more tablets than you have been told to take, or if someone else accidentally takes your tablets, contact your doctor or hospital for advice immediately. Show them your pack of tablets.
If you forget to take a tablet, take your tablet as soon as you remember, but do not take more than one tablet in one day. Do not take a double dose to make up for a forgotten tablet.
Do not stop taking Fesoterodine without talking to your doctor, as your symptoms of overactive bladder may come back again or become worse once you stop taking Fesoterodine.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Serious allergic reactions including angioedema occurred rarely. You should stop taking Fesoterodine and contact your doctor immediately if you develop swelling of the face, mouth or throat as this may be life-threatening.
Very common (may affect more than 1 in 10 people)
You may get a dry mouth. This effect is usually mild or moderate. This may lead to a greater risk of dental caries. Therefore, you should brush your teeth regularly twice daily and see a dentist when in doubt.
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme (Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store). By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and the blister after “EXP”. The expiry date refers to the last day of that month.
Fesoterodine fumarate 4mg prolonged-release tablets
Do not store above 30°C.
Fesoterodine fumarate 8mg prolonged-release tablets
This medicinal product does not require any special temperature storage conditions.
Store in the original package in order to protect from moisture.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
Fesoterodine fumarate 4mg
Each prolonged-release tablet contains 4mg fesoterodine fumarate, equivalent to 3.1mg of fesoterodine.
Fesoterodine fumarate 8mg
Each prolonged-release tablet contains 8mg fesoterodine fumarate, equivalent to 6.2mg of fesoterodine.
Fesoterodine fumarate 4mg and 8mg
The tablet core: lactose monohydrate, microcrystalline cellulose, hypromellose, glycerol dibehenate, talc.
The coating:
Fesoterodine fumarate 4mg
polyvinyl alcohol, titanium dioxide, glycerol monocaprylocaprate (type I), talc, sodium laurilsulfate, indigo carmine aluminium lake.
Fesoterodine fumarate 8mg
polyvinyl alcohol, titanium dioxide, glycerol monocaprylocaprate (type I), talc, sodium laurilsulfate, carmine aluminium lake, iron oxide red.
Fesoterodine fumarate 4mg prolonged-release tablets are light blue, oval, curved outwards on both sides and film-coated with dimensions 13.1mm ± 0.2 mm x 6.6mm ± 0.2 mm and engraved on one side with the number '4'.
Fesoterodine fumarate 8mg prolonged-release tablets are blue, oval, curved outwards on both sides and film-coated with dimensions 13.1mm ± 0.2 mm x 6.6mm ± 0.2 mm and engraved on one side with the number '8'.
Fesoterodine fumarate is available in blister packs of 10, 14, 20, 28, 30, 40, 42, 50, 56, 60, 70, 80, 84, 90, 98 or 100 prolonged-release tablets.
Please note that not all the above pack sizes may be marketed.
Marketing Authorisation Holder:
Manufacturer:
This leaflet was last revised in September 2024
1010558-P3.1
4 Rotherbrook Court, Bedford Road, Petersfield, Hampshire, GU32 3QG, UK
+44 (0)1730 231148
http://www.aspirepharma.co.uk
+44 (0)1730 231148
+44 (0)1730 231148